Document Type : Original Article
Authors
1 Surgical Oncology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Faculty of Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Education and Research Department, Razavi Hospital, Mashhad, IR Iran
Abstract
Keywords
Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/
1. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med. 2007;356(22):2301-11. https://doi.org/10.1056/NEJMra067742 PMid:17538089 |
||||
2. Esmaeelzadeh M, Amini S. The effect of tranexamic acide on cardiac surgery bleeding. Rev Clin Med. 2014;1(1):7-11. | ||||
3. Daly DJ, Myles PS, Smith JA, Knight JL, Clavisi O, Bain DL, et al. Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice. Anaesth Intensive Care. 2007;35(5):760-8. https://doi.org/10.1177/0310057X0703500516 PMid:17933164 |
||||
4. Rogers MA, Blumberg N, Saint SK, Kim C, Nallamothu BK, Langa KM. Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J. 2006;152(6):1028-34. https://doi.org/10.1016/j.ahj.2006.07.009 PMid:17161047 |
||||
5. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544-52. https://doi.org/10.1161/CIRCULATIONAHA.107.698977 PMid:17998460 |
||||
6. McQuilten ZK, Andrianopoulos N, Wood EM, Cole-Sinclair MF, McNeil JJ, Cameron PA, et al. Transfusion practice varies widely in cardiac surgery: Results from a national registry. J Thorac Cardiovasc Surg. 2014;147(5):1684-1690 e1. https://doi.org/10.1016/j.jtcvs.2013.10.051 PMid:24332109 |
||||
7. Blajchman MA, Vamvakas EC. The continuing risk of transfusiontransmitted infections. N Engl J Med. 2006;355(13):1303-5. https://doi.org/10.1056/NEJMp068178 PMid:17005947 |
||||
8. Mannucci PM. Hemostatic drugs. N Engl J Med. 1998;339(4):245-53. https://doi.org/10.1056/NEJM199807233390407 PMid:9673304 |
||||
9. Lange M, Van Aken H, Westphal M. Prevention and treatment of major blood loss. N Engl J Med. 2007;357(12):1260. https://doi.org/10.1056/NEJMc071849 |
||||
10. Michelson AD, Barnard MR. Plasmin-induced redistribution of platelet glycoprotein Ib. Blood. 1990;76(10):2005-10. https://doi.org/10.1182/blood.V76.10.2005.bloodjournal76102005 https://doi.org/10.1182/blood.V76.10.2005.2005 |
||||
11. Larson A. Deliberate hypotension. Anesthesiology. 2009;25(1) | ||||
12. Pilli G, Guzeldemir ME, Bayhan N. Esmolol for hypotensive anesthesia in middle ear surgery. Acta Anaesthesiol Belg. 1996;47(2):85-91. | ||||
13. Degoute CS. Controlled hypotension: a guide to drug choice. Drugs. 2007;67(7):1053-76. https://doi.org/10.2165/00003495-200767070-00007 PMid:17488147 |
||||
14. Amaranath L, Kellermeyer WJ. Tachyphylaxis to sodium nitroprusside. Anesthesiology. 1976;44(4):345-8. https://doi.org/10.1097/00000542-197604000-00016 PMid:1259195 |
||||
15. van der Linden J, Lindvall G, Sartipy U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. Circulation. 2005;112(9 Suppl):I276-80. https://doi.org/10.1161/CIRCULATIONAHA.104.524611 |
||||
16. Lindvall G, Sartipy U, van der Linden J. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Ann Thorac Surg. 2005;80(3):922-7. https://doi.org/10.1016/j.athoracsur.2005.03.079 PMid:16122456 |
||||
17. Okubadejo GO, Bridwell KH, Lenke LG, Buchowski JM, Fang DD, Baldus CR, et al. Aprotinin may decrease blood loss in complex adult spinal deformity surgery, but it may also increase the risk of acute renal failure. Spine (Phila Pa 1976). 2007;32(20):2265-71. https://doi.org/10.1097/BRS.0b013e31814ce9b0 PMid:17873821 |
||||
18. Tayyab NA, Mariller MM, Rivlin M, Berekashvili K, Bitan FD, Casden AM, et al. Efficacy of aprotinin as a blood conservation technique for adult deformity spinal surgery: a retrospective study. Spine (Phila Pa 1976). 2008;33(16):1775-81. https://doi.org/10.1097/BRS.0b013e31817b87c4 PMid:18628710 |
||||
19. Bai SC, Wang JY, Qin GP. Combined using Aprotinin, Hemodilution andinduced Hypotention in patients undergoing eurosurgery. Acta Academiae Medicinae Neimongol. 2008;1:7. | ||||
20. Pleym H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesthesia Analgesia. 2003;96(4):923-8. https://doi.org/10.1213/01.ANE.0000054001.37346.03 PMid:12651635 |
||||
21. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054. https://doi.org/10.1136/bmj.e3054 PMid:22611164 PMCid:PMC3356857 |